Endemic Mycoses on the African Continent
A. V. Lipnitsky,
A. A. Murugova,
N. V. Polovets,
E. V. Naidenova,
A. Camara,
M. S. Diallo,
J.-C. Mobousse Misse,
S. Boumbaly,
M. S. Traore,
I. I. Korsakova https://doi.org/10.21055/0370-1069-2025-3-68-74
Abstract
The review of the current microbiological, epidemiological and diagnostic aspects of some endemic mycoses (histoplasmosis, blastomycosis, emergomycosis) found on the African continent is brought forward. Other endemic mycoses (coccidioidomycosis, paracoccidioidomycosis, talaromycosis) have not been described in Africa and can only be imported. Histoplasmosis caused by Histoplasma capsulatum var. capsulatum is widespread in the world, but Africa is the only continent where two variants coexist – H. capsulatum and H. duboisii. The latter is the causative agent of the disease called “african histoplasmosis”. Disseminated forms of histoplasmosis are diagnosed in 5–20 % of HIV-infected individuals. African cases of blastomycosis are caused predominantly by Blastomyces percursus and B. emzantsi species, which differ significantly from the etiologic agents of this disease in North America (B. dermatitidis and B. gilchristii). The number of diagnosed cases of endemic mycoses in Africa has increased significantly in the last decade, which may be due to a new disease, emergomycosis. One of the etiologic agents of this mycosis is the dimorphic fungus Emergomyces africanus. Laboratory diagnostics of endemic mycoses in most African countries is limited due to the lack of experienced personnel and advanced test systems.
About the Authors
A. V. Lipnitsky
Volgograd Research Anti-Plague Institute
Russian Federation
Russian Federation
7, Golubinskaya St., Volgograd, 400131
A. A. Murugova
Volgograd Research Anti-Plague Institute
Russian Federation
Russian Federation
7, Golubinskaya St., Volgograd, 400131
N. V. Polovets
Volgograd Research Anti-Plague Institute
Russian Federation
Russian Federation
7, Golubinskaya St., Volgograd, 400131
E. V. Naidenova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
46, Universitetskaya St., Saratov, 410005
A. Camara
Gamal Abdel Nasser University
Guinea
Guinea
Faculty of Medicine and Health Sciences
Conakry
M. S. Diallo
Gamal Abdel Nasser University
Guinea
Guinea
Faculty of Medicine and Health Sciences
Conakry
J.-C. Mobousse Misse
Ministry of Health and Population of the Republic of the Congo
Congo
Congo
Brazzaville
S. Boumbaly
Gamal Abdel Nasser University
Guinea
Guinea
Faculty of Medicine and Health Sciences
Conakry
M. S. Traore
Research Institute of Applied Biology of Guinea
Guinea
Guinea
Kindia
I. I. Korsakova
Volgograd Research Anti-Plague Institute
Russian Federation
Russian Federation
7, Golubinskaya St., Volgograd, 400131
References
1. WHO – HIV and AIDS. (Cited 31 Jule 2025). [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids.
2. GAFFI – Africa Diagnostic report. (Cited 31 Jule 2025). [Internet]. Available from: https://gaffi.org/africa-diagnosticreports-2/.
3. Vallabhaneni S., Mody R.K., Walker T., Chiller T. The global burden of fungal diseases. Infect. Dis. Clin. North Am. 2016; 30(1):1–11. DOI: 10.1016/j.idc.2015.10.004.
4. Oladele R.O., Ayanlowo O.O., Richardson M.D., Denning D.W. Histoplasmosis in Africa: An emerging or a neglected disease? PLoS Negl. Trop. Dis. 2018; 12(1):e0006046. DOI: 10.1371/journal. pntd.0006046.
5. Régnier-Rosencher E., Dupont B., Jacobelli S., Paugam A., Carlotti A., Boitier F., Gorin I., Dupin N., Avril M.F. Late occurrence of Histoplasma duboisii cutaneous and pulmonary infection 18 years after exposure. J. Mycol. Med. 2014; 24(3):229–33. DOI: 10.1016/j. mycmed.2014.08.001.
6. Develoux M., Amona F.M., Hennequin C. Histoplasmosis caused by Histoplasma capsulatum var. duboisii: A comprehensive review of cases from 1993 to 2019. Clin. Infect. Dis. 2021; 73(3):e543-e549. DOI: 10.1093/cid/ciaa1304.
7. Antinori S., Giacomelli A., Corbellino M., Torre A., Schiuma M., Casalini G., Parravicini C., Milazzo L., Gervasoni C., Ridolfo A.L. Histoplasmosis diagnosed in Europe and Israel: A case report and systematic review of the literature from 2005 to 2020. J. Fungi (Basel). 2021; 7(6):481. DOI: 10.3390/jof7060481.
8. Amona F.M., Denning D.W., Moukassa D., Develoux M., Hennequin C. Histoplasmosis in the Republic of Congo dominated by African histoplasmosis, Histoplasma capsulatum var. duboisii. PLoS Negl. Trop. Dis. 2021; 15(5):e0009318. DOI: 10.1371/journal. pntd.0009318.
9. Audebaud G., Merveille P., Laluque P., Depoux R. [First case of histoplasmosis in French Equatorial Africa]. Bull. Soc. Pathol. Exot. Filiales. 1954; 47(6):803–8. PMID: 14378918.
10. Kwizera R., Bongomin F., Lukande R. Deep fungal infections diagnosed by histology in Uganda: a 70-year retrospective study. Med. Mycol. 2020; 58(8):1044–52. DOI: 10.1093/mmy/myaa018.
11. Bahr N.C., Sarosi G.A., Meya D.B., Bohjanen P.R., Richer S.M., Swartzentruber S., Halupnick R., Jarrett D., Wheat L.J., Boulware D.R. Seroprevalence of histoplasmosis in Kampala, Uganda. Med. Mycol. 2016; 54(3):295–300. DOI: 10.1093/mmy/myv081.
12. Cottle L.E., Gkrania-Klotsas E., Williams H.J., Brindle H.E., Carmichael A.J., Fry G., Beeching N.J. A multinational outbreak of histoplasmosis following a biology field trip in the Ugandan rainforest. J. Travel. Med. 2013; 20(2):83–7. DOI: 10.1111/jtm.12012.
13. Pakasa N., Biber A., Nsiangana S., Imposo D., Sumaili E., Muhindo H., Buitrago M.J., Barshack I., Schwartz E. African histoplasmosis in HIV-negative patients, Kimpese, Democratic Republic of the Congo. Emerg. Infect. Dis. 2018; 24(11):2068–70. DOI: 10.3201/eid2411.180236.
14. Mapengo R.E., Maphanga T.G., Grayson W., Govender N.P. Endemic mycoses in South Africa, 2010–2020: A decade-long description of laboratory-diagnosed cases and prospects for the future. PLoS Negl. Trop. Dis. 2022; 16(9):e0010737. DOI: 10.1371/journal.pntd.0010737.
15. Cockshott W.P., Lucas A.O. Histoplasmosis duboisii. Q. J. Med. 1964; 33:223–38. PMID: 14152972.
16. Valero C., Gago S., Monteiro M.C., Alastruey-Izquierdo A., Buitrago M.J. African histoplasmosis: new clinical and microbiological insights. Med. Mycol. 2018; 56(1):51–9. DOI: 10.1093/mmy/myx020.
17. Ekeng B.E., Edem K., Akintan P., Oladele R.O. Histoplasmosis in African children: clinical features, diagnosis and treatment. Ther. Adv. Infect. Dis. 2022; 9:20499361211068592. DOI: 10.1177/20499361211068592.
18. García-Marrón M., García-García J.M., Pajín-Collada M., Alvarez-Navascués F., Martínez-Muñiz M.A., Sánchez-Antuña A.A. [Chronic pulmonary histoplasmosis diagnosed in a nonimmunosuppressed patient 10 years after returning from an endemic area]. Arch. Bronconeumol. 2008; 44(10):567–70. PMID: 19006637.
19. Agudelo C.A., Restrepo C.A., Molina D.A., Tobón A.M., Kauffman C.A., Murillo C., Restrepo A. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am. J. Trop. Med. Hyg. 2012; 87(6):1094–8. DOI: 10.4269/ajtmh.2012.12-0292.
20. de Hoog G.S., Guarro J., Gené J., Ahmed S.A., Al-Hatmi A.M.S., Figueras M.J., Vitale R.G. Atlas of Clinical Fungi: The ultimate benchtool for diagnostics. Part α: Introductions, lower fungi, basidiomycetes, yeasts, filamentous ascomycetes A-B. 4th edition. Foundation Atlas of Clinical Fungi; 2020. ISBN 978-94-93226-12-8.
21. Guarner J., Brandt M.E. Histopathologic diagnosis of fungal infections in the 21st century. Clin. Microbiol. Rev. 2011; 24(2):247–80. DOI: 10.1128/CMR.00053-10.
22. Almeida-Paes R., Bernardes-Engemann A.R., da Silva Motta B., Pizzini C.V., de Abreu Almeida M., de Medeiros Muniz M., Dias R.A.B., Zancopé-Oliveira R.M. Immunologic diagnosis of endemic mycoses. J. Fungi (Basel). 2022; 8(10):993. DOI: 10.3390/jof8100993.
23. Vasconcellos I.C.D.S., Dalla Lana D.F., Pasqualotto A.C. The role of molecular tests in the diagnosis of disseminated histoplasmosis. J. Fungi (Basel). 2019; 6(1):1. DOI: 10.3390/jof6010001.
24. Kneale M., Bartholomew J.S., Davies E., Denning D.W. Global access to antifungal therapy and its variable cost. J. Antimicrob. Chemother. 2016; 71(12):3599–606. DOI: 10.1093/jac/dkw325.
25. de Hoog G.S., Redhead S.A., Feng P., Jiang Y., Dukik K., Sigler L. (2465–2466) Proposals to conserve Blastomyces Gilchrist & W.R. Stokes against Blastomyces Costantin & Rolland and Ajellomycetaceae against Paracoccidioidaceae (Ascomycota: Onygenales). Taxon. 2016; 65:1167–9. DOI: 10.12705/655.19.
26. Brown E.M., McTaggart L.R., Zhang S.X., Low D.E., Stevens D.A., Richardson S.E. Correction: phylogenetic analysis reveals a cryptic species Blastomyces gilchristii, sp. nov. within the human pathogenic fungus Blastomyces dermatitidis. PLoS One. 2016; 11(12):e0168018. DOI: 10.1371/journal.pone.0168018.
27. Schwartz I.S., Wiederhold N.P., Patterson T.F., Sigler L. Blastomyces helicus, a new dimorphic fungus causing fatal pulmonary and systemic disease in humans and animals in Western Canada and United States. Clin. Infect. Dis. 2019; 68(2):188–95. DOI: 10.1093/cid/ciy483.
28. Maphanga T.G., Birkhead M., Muñoz J.F., Allam M., Zulu T.G., Cuomo C.A., Schwartz I.S., Ismail A., Naicker S.D., Mpembe R.S., Corcoran C., de Hoo S., Kenyon C., Borman A.M., Frean J.A., Govender N.P. Human blastomycosis in South Africa caused by Blastomyces percursus and Blastomyces emzantsi sp. nov., 1967 to 2014. J. Clin. Microbiol. 2020; 58(3):e01661-19. DOI: 10.1128/jcm.01661-19.
29. Jiang Y., Dukik K., Munoz J.F., Sigler L., Schwartz I.S., Govender N.P., Kenyon C., Feng P., Gerrits van den Ende B., Stielow J.B., Stchigel A.M., H. Lu, de Hoog S. Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis. Fungal Diversity. 2018; 90:245–91. DOI: 10.1007/s13225-018-0403-y.
30. Carman W.F., Frean J.A., Crewe-Brown H.H., Culligan G.A., Young C.N. Blastomycosis in Africa. A review of known cases diagnosed between 1951 and 1987. Mycopathologia. 1989; 107(1):25–32. DOI: 10.1007/BF00437587.
31. Schwartz I.S., Muñoz J.F., Kenyon C.R., Govender N.P., McTaggart L., Maphanga T.G., Richardson S., Becker P., Cuomo C.A., McEwen J.G., Sigler L. Blastomycosis in Africa and the Middle East: A comprehensive review of reported cases and reanalysis of historical isolates based on molecular data. Clin. Infect. Dis. 2021; 73(7): e1560-e1569. DOI: 10.1093/cid/ciaa1100.
32. Dukik K., Muñoz J.F., Jiang Y., Feng P., Sigler L., Stielow J.B., Freeke J., Jamalian A., Gerrits van den Ende B., McEwen J.G., Clay O.K., Schwartz I.S., Govender N.P., Maphanga T.G., Cuomo C.A., Moreno L.F., Kenyon C., Borman A.M., de Hoog S. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses. 2017; 60(5):296–309. DOI: 10.1111/myc.12601.
33. American Type Culture Collection. Emmonsia parva (Emmons et Ashburn) Ciferri et Montemartini, teleomorph (ATCC® 56220™). (Cited 09 June 2025). [Internet]. Available from: https://www.atcc.org/products/all/56220.aspx#specifications.
34. Finkel-Jimenez B., Wüthrich M., Klein B.S. BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms. J. Immunol. 2002; 168(11):5746–55. DOI: 10.4049/jimmunol.168.11.5746.
35. Klein B.S., Aizenstein B.D., Hogan L.H. African strains of Blastomyces dermatitidis that do not express surface adhesin WI-1. Infect. Immun. 1997; 65(4):1505–9. DOI: 10.1128/iai.65.4.1505-1509.1997.
36. Vandepitte J., Gatti F. [A case of North American blastomycosis in Africa. Its existence in Republic of Zaire]. Ann. Soc. Belg. Med. Trop. 1972; 52(4):467–79. PMID: 5070641.
37. Crampton T.L., Light R.B., Berg G.M., Meyers M.P., Schroeder G.C., Hershfield E.S., Embil J.M. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin. Infect. Dis. 2002; 34(10):1310–6. DOI: 10.1086/340049.
38. Lemos L.B., Baliga M., Guo M. Blastomycosis: The great pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann. Diagn. Pathol. 2002; 6(3):194–203. DOI: 10.1053/adpa.2002.34575.
39. Baumgardner D.J., Buggy B.P., Mattson B.J., Burdick J.S., Ludwig D. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin. Infect. Dis. 1992; 15(4):629– 35. DOI: 10.1093/clind/15.4.629.
40. Gugnani H.C., Muotoe-Okafor F. African histoplasmosis: a review. Rev. Iberoam. Micol. 1997; 14(4):155–9. PMID: 15538817.
41. Frost H.M., Novicki T.J. Blastomyces antigen detection for diagnosis and management of blastomycosis. J. Clin. Microbiol. 2015; 53(11):3660–2. DOI: 10.1128/JCM.02352-15.
42. Girouard G., Lachance C., Pelletier R. Observations on (1-3)-beta-D-glucan detection as a diagnostic tool in endemic mycosis caused by Histoplasma or Blastomyces. J. Med. Microbiol. 2007; 56(Pt. 7):1001–2. DOI: 10.1099/jmm.0.47162-0.
43. Theel E.S., Rodino K.G., Granger D. Detection of Blastomyces dermatitidis antigen in urine using a commercially available quantitative enzyme immunoassay. J. Clin. Microbiol. 2021; 59(10):e0144421. DOI: 10.1128/JCM.01444-21.
44. Sidamonidze K., Peck M.K., Perez M., Baumgardner D., Smith G., Chaturvedi V., Chaturvedi S. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J. Clin. Microbiol. 2012; 50(5):1783–6. DOI: 10.1128/JCM.00310-12.
45. Thompson G.R. 3rd, Le T., Chindamporn A., Kauffman C.A., Alastruey-Izquierdo A., Ampel N.M., Andes D.R., ArmstrongJames D., Ayanlowo O., Baddley J.W., Barker B.M., Lopes Bezerra L., Buitrago M.J., Chamani-Tabriz L., Chan J.F.W., Chayakulkeeree M., Cornely O.A., Cunwei C., Gangneux J.P., Govender N.P., Hagen F., Hedayati M.T., Hohl T.M., Jouvion G., Kenyon C., Kibbler C.C., Klimko N., Kong D.C.M., Krause R., Lee Lee L., Meintjes G., Miceli M.H., Rath P.M., Spec A., Queiroz-Telles F., Variava E., Verweij P.E., Schwartz I.S., Pasqualotto A.C. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect. Dis. 2021; 21(12):e364-e374. DOI: 10.1016/S1473-3099(21)00191-2.
46. Dukik K., Al-Hatmi A.M.S., Curfs-Breuker I., Faro D., de Hoog S., Meis J.F. Antifungal susceptibility of emerging dimorphic pathogens in the family Ajellomycetaceae. Antimicrob. Agents Chemother. 2017; 62(1):e01886-17. DOI: 10.1128/AAC.01886-17.
47. Drouhet E., Guého E., Gori S., Huerre M.R., Provost F., Borgers M., Dupont B.F. Mycological, ultrastructural and experimental aspects of a new dimorphic fungus Emmonsia pasteuriana sp. nov. isolated from a cutaneous disseminated mycosis in AIDS. J. Mycol. Med. 1998; 8(2):64–77.
48. Wang P., Kenyon C., de Hoog S., Guo L., Fan H., Liu H., Li Z., Sheng R., Yang Y., Jiang Y., Zhang L., Xu Y. A novel dimorphic pathogen, Emergomyces orientalis (Onygenales), agent of disseminated infection. Mycoses. 2017; 60(5):310–9. DOI: 10.1111/myc.12583.
49. Kenyon C., Bonorchis K., Corcoran C., Meintjes G., Locketz M., Lehloenya R., Vismer H.F., Naicker P., Prozesky H., van Wyk M., Bamford C., du Plooy M., Imrie G., Dlamini S., Borman A.M., Colebunders R., Yansouni C.P., Mendelson M., Govender N.P. A dimorphic fungus causing disseminated infection in South Africa. N. Engl. J. Med. 2013; 369(15):1416–24. DOI: 10.1056/NEJMoa1215460.
50. Schwartz I.S., Govender N.P., Corcoran C., Dlamini S., Prozesky H., Burton R., Mendelson M., Taljaard J., Lehloenya R., Calligaro G., Colebunders R., Kenyon C. Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: A retrospective case series. Clin. Infect. Dis. 2015; 61(6):1004–12. DOI: 10.1093/cid/civ439.
51. Lochan H., Naicker P., Maphanga T., Ryan A., Pillay K., Govender N.P., Eley B. A case of emmonsiosis in an HIV-infected child. South Afr. J. HIV Med. 2015; 16(1):352. DOI: 10.4102/sajhivmed.v16i1.352.
52. Bhagoobhai L., Seetharam S., Wadula J. Dimorphic fungus (Emmonsia species) isolated from sterile sites between March 2014 to April 2015. In: 6th FIDSSA Congress 2015. South African Journal of Infectious Diseases; 2015. P. 120–75.
53. Feng P., Yin S., Zhu G., Li M., Wu B., Xie Y., Ma H., Zhang J., Cheng C., de Hoog G.S., Lu C., Lai W. Disseminated infection caused by Emmonsia pasteuriana in a renal transplant recipient. J. Dermatol. 2015; 42(12):1179–82. DOI: 10.1111/1346-8138.12975.
54. Maphanga T.G., Britz E., Zulu T.G., Mpembe R.S., Naicker S.D., Schwartz I.S., Govender N.P. In vitro antifungal susceptibility of yeast and mold phases of isolates of dimorphic fungal pathogen Emergomyces africanus (formerly Emmonsia sp.) from HIV-infected South African patients. J. Clin. Microbiol. 2017; 55(6):1812–20. DOI: 10.1128/JCM.02524-16.
55. Schwartz I.S., Lerm B., Hoving J.C., Kenyon C., Horsnell W.G., Basson W.J., Otieno-Odhiambo P., Govender N.P., Colebunders R., Botha A. Emergomyces africanus in Soil, South Africa. Emerg. Infect. Dis. 2018; 24(2):377–80. DOI: 10.3201/eid2402.171351.
56. Schwartz I.S., McLoud J.D., Berman D., Botha A., Lerm B., Colebunders R., Levetin E., Kenyon C. Molecular detection of airborne Emergomyces africanus, a thermally dimorphic fungal pathogen, in Cape Town, South Africa. PLoS Negl. Trop. Dis. 2018; 12(1):e0006174. DOI: 10.1371/journal.pntd.0006174.
57. Cronjé N., Schwartz I.S., Retief L., Bastos A.D.S., Matthee S., Preiser W., Bennett N.C., Maphanga T., Govender N.P., Colebunders R., Kenyon C. Attempted molecular detection of the thermally dimorphic human fungal pathogen Emergomyces africanus in terrestrial small mammals in South Africa. Med. Mycol. 2018; 56(4):510–3. DOI: 10.1093/mmy/myx065.
58. Wilmes D., Rooms I., Heidemarie L., McCormick Smith I., Haase G., Rickerts V. Emergomycosis: Case report of a disseminated Emergomyces pasteurianus infection and review of an emerging fungal infection. In: 52nd Scientific Conference of the German Speaking Mycological Society (DMykG) together with the Austrian Society for Medical Mycology (ÖGMM), Sep. 06–08, 2018. Innsbruck, Austria: Mycoses; 2018.
59. Rooms I., Mugisha P., Gambichler T., Hadaschik E., Esser S., Rath P.M., Haase G., Wilmes D., McCormick-Smith I., Rickerts V. Disseminated emergomycosis in a person with HIV infection, Uganda. Emerg. Infect. Dis. 2019; 25(9):1750–1. DOI: 10.3201/eid2509.181234.
60. Crombie K., Spengane Z., Locketz M., Dlamini S., Lehloenya R., Wasserman S., Maphanga T.G., Govender N.P., Kenyon C., Schwartz I.S. Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy. PLoS Negl. Trop. Dis. 2018; 12(3):e0006173. DOI: 10.1371/journal.pntd.0006173.
Review
For citations:
Lipnitsky A.V., Murugova A.A., Polovets N.V., Naidenova E.V., Camara A., Diallo M.S., Mobousse Misse J., Boumbaly S., Traore M.S., Korsakova I.I. Endemic Mycoses on the African Continent. Problems of Particularly Dangerous Infections. 2025;(3):68-74. (In Russ.) https://doi.org/10.21055/0370-1069-2025-3-68-74
Views:
7
Email this article 